Increasing global burden of cardiovascular disease in general populations and patients with schizophreniaHENNEKENS, Charles H.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 4, pp 4-13, 10 p.Article

Current perspectives on lipid lowering with statins to decrease risk of cardiovascular diseaseHENNEKENS, Charles H.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, pp II.2-II5, SUP2Article

Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy MenHAYASHINO, Yasuaki; HENNEKENS, Charles H; KURTH, Tobias et al.The American journal of medicine. 2009, Vol 122, Num 4, pp 374-379, issn 0002-9343, 6 p.Article

The Patient with Metabolic Disorders and/or Cardiovascular Disease: New and Emerging ConceptsHENNEKENS, Charles H; PFEFFER, Marc A.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, 21 p., SUP2Serial Issue

Homocysteine and cardiovascular disease: Biological mechanisms, observational epidemiology, and the need for randomized trialsSPLAVER, Adam; LAMAS, Gervasio A; HENNEKENS, Charles H et al.The American heart journal. 2004, Vol 148, Num 1, pp 34-40, issn 0002-8703, 7 p.Article

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular diseaseHEBERT, Patricia R; HENNEKENS, Charles H.Archives of internal medicine (1960). 2000, Vol 160, Num 20, pp 3123-3127, issn 0003-9926Article

Treating mixed dyslipidemias : Why and howBALLANTYNE, Christie M.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, pp II.6-II9, SUP2Article

Terms and conditions: Semantic complexity and aspirin resistanceHENNEKENS, Charles H; SCHROR, Karsten; WEISMAN, Steven et al.Circulation (New York, N.Y.). 2004, Vol 110, Num 12, pp 1706-1708, issn 0009-7322, 3 p.Article

Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health studyCOOK, Nancy R; COLE, Stephen R; HENNEKENS, Charles H et al.American journal of epidemiology. 2002, Vol 155, Num 11, pp 1045-1053, issn 0002-9262Article

Use of Aspirin Among Diabetics in the Primary Prevention of Cardiovascular Disease: Need For Reliable Randomized Evidence and Astute Clinical JudgmentHEBERT, Patricia R; SCHNEIDER, Wendy R; HENNEKENS, Charles H et al.Journal of general internal medicine. 2009, Vol 24, Num 11, pp 1248-1250, issn 0884-8734, 3 p.Article

The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) programPOCOCK, Stuart; DUOLAO WANG; WILHELMSEN, Lars et al.The American heart journal. 2005, Vol 149, Num 5, pp 939-943, issn 0002-8703, 5 p.Article

N-Acetylcysteine and contrast-induced nephropathy : A meta-analysis of 13 randomized trialsZAGLER, Axel; AZADPOUR, Maziar; MERCADO, Carlos et al.The American heart journal. 2005, Vol 151, Num 1, pp 140-145, issn 0002-8703, 6 p.Article

Newer HMGg-CoA reductase inhibitor (statin) therapiesBRINTON, Eliot A.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, pp II.10-II.13, SUP2Article

Statins : A brief summaryPFEFFER, Marc A.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, p. II-18, SUP2Article

Management of metabolic syndrome: aspirinSHIELDS, T. Matthew; HENNEKENS, Charles H.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 3, issn 0889-8529, vii, 577-593 [18 p.]Article

Genetic markers for Coronary heart diseaseBRESLOW, Jan L.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, pp II.14-II.17, SUP2Article

Low Rates of Reporting Commercial Bias by Physicians Followino Online Continuino Medical Education ActivitiesELLISON, Julie A; HENNEKENS, Charles H; JING WANG et al.The American journal of medicine. 2009, Vol 122, Num 9, pp 875-878, issn 0002-9343, 4 p.Article

Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: A review and qualitative overview of the prospective cohort studiesMONTANEZ, Alicia; RUSKIN, Jeremy N; HEBERT, Patricia R et al.Archives of internal medicine (1960). 2004, Vol 164, Num 9, pp 943-948, issn 0003-9926, 6 p.Article

Vitamin supplement Use in a low-risk population of US male physicians and subsequent cardiovascular mortalityMUNTWYLER, Jorg; HENNEKENS, Charles H; MANSON, Joann E et al.Archives of internal medicine (1960). 2002, Vol 162, Num 13, pp 1472-1476, issn 0003-9926Article

Schizophrenia and increased risks of cardiovascular diseaseHENNEKENS, Charles H; HENNEKENS, Alissa R; HOLLAR, Danielle et al.The American heart journal. 2005, Vol 150, Num 6, pp 1115-1121, issn 0002-8703, 7 p.Article

An update on aspirin in the primary prevention of cardiovascular diseaseEIDELMAN, Rachel S; HEBERT, Patricia R; WEISMAN, Steven M et al.Archives of internal medicine (1960). 2003, Vol 163, Num 17, pp 2006-2010, issn 0003-9926, 5 p.Article

Evidence base for pacemaker mode selection: From physiology to randomized trialsLAMAS, Gervasio A; ELLENBOGEN, Kenneth A; HENNEKENS, Charles H et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 4, pp 443-451, issn 0009-7322, 9 p.Article

Brain natriuretic peptide: a potential marker for mortality in septic shockCASTILLO, Jose R; ZAGLER, Axel; CARRILLO-JIMENEZ, Rodolfo et al.International journal of infectious diseases. 2004, Vol 8, Num 5, pp 271-274, issn 1201-9712, 4 p.Article

A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physiciansMANSON, Joann E; AJANI, Umed A; SIMIN LIU et al.The American journal of medicine. 2000, Vol 109, Num 7, pp 538-542, issn 0002-9343Article

Randomized trials of vitamin E in the treatment and prevention of cardiovascular diseaseEIDELMAN, Rachel S; HOLLAR, Danielle; HEBERT, Patricia R et al.Archives of internal medicine (1960). 2004, Vol 164, Num 14, pp 1552-1556, issn 0003-9926, 5 p.Article